Wnt signaling in estrogen-induced lactotroph proliferation

A. Giles, F. Madec, S. Friedrichsen, K. Featherstone, T. Chambers, C. V. Harper, J. Resch, G. Brabant, J. R. E. Davis


Prolactinomas are the most common type of functioning pituitary adenoma in humans, but the control of lactotroph proliferation remains unclear. Here, using microarray analysis, we show that estrogen treatment increased expression of Wnt4 mRNA in adult Fischer rat pituitary tissue. Dual immunofluorescence analysis revealed that Wnt4 expression was not confined to lactotrophs, but that it was expressed in all anterior pituitary cell types. Estradiol induced proliferation in the somatolactotroph GH3 cell line, in parallel with Wnt4 mRNA and protein induction. A reporter gene assay for TCF- and LEF-dependent transcription revealed that there was no activation of the canonical Wnt pathway in GH3 cells upon stimulation with Wnt-conditioned culture medium or coexpression of constitutively active mutant beta-catenin. Expression of beta-catenin in both GH3 cells and normal rat anterior pituitary cells was restricted to the cell membrane and was unaltered by treatment with estradiol, with no nuclear beta-catenin being detected under any of the conditions tested. We show for the first time that Wnt4 affects non-canonical signaling in the pituitary by inhibiting Ca(2+) oscillations in GH3 cells, although the downstream effects are as yet unknown. In summary, Wnt4 is expressed in the adult pituitary gland, and its expression is increased by estrogen exposure, suggesting that its involvement in adult tissue plasticity is likely to involve beta-catenin-independent signaling pathways
Original languageEnglish
Title of host publicationJournal of Cell Science
Number of pages8
Publication date15.02.2011
ISBN (Print)1477-9137 (Electronic)\n0021-9533 (Linking)
Publication statusPublished - 15.02.2011


Dive into the research topics of 'Wnt signaling in estrogen-induced lactotroph proliferation'. Together they form a unique fingerprint.

Cite this